Mackenzie Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.45M | Buy |
22,507
+10,112
| +82% | +$3.44M | 0.01% | 580 |
|
|
2025
Q4 | $4.91M | Buy |
12,395
+2,622
| +27% | +$1.16M | 0.01% | 644 |
|
|
2025
Q3 | $4.46M | Buy |
9,773
+698
| +8% | +$284K | 0.01% | 657 |
|
|
2025
Q2 | $2.96M | Sell |
9,075
-410
| -4% | -$113K | ﹤0.01% | 700 |
|
|
2025
Q1 | $2.56M | Buy |
9,485
+626
| +7% | +$161K | ﹤0.01% | 706 |
|
|
2024
Q4 | $2.08M | Sell |
8,859
-10,832
| -55% | -$2.85M | ﹤0.01% | 759 |
|
|
2024
Q3 | $5.42M | Sell |
19,691
-16,400
| -45% | -$4.27M | 0.01% | 531 |
|
|
2024
Q2 | $8.77M | Buy |
36,091
+17,576
| +95% | +$2.77M | 0.01% | 457 |
|
|
2024
Q1 | $2.77M | Sell |
18,515
-1,821
| -9% | -$304K | ﹤0.01% | 671 |
|
|
2023
Q4 | $3.89M | Sell |
20,336
-1,410
| -6% | -$240K | 0.01% | 604 |
|
|
2023
Q3 | $3.76M | Sell |
21,746
-8,350
| -28% | -$1.59M | 0.01% | 592 |
|
|
2023
Q2 | $5.71M | Buy |
30,096
+4,299
| +17% | +$852K | 0.01% | 529 |
|
|
2023
Q1 | $5.17M | Buy |
25,797
+580
| +2% | +$122K | 0.01% | 541 |
|
|
2022
Q4 | $5.99M | Buy |
25,217
+1,703
| +7% | +$363K | 0.01% | 493 |
|
|
2022
Q3 | $4.71M | Buy |
23,514
+2,508
| +12% | +$478K | 0.01% | 540 |
|
|
2022
Q2 | $3.06M | Buy |
21,006
+1,630
| +8% | +$231K | ﹤0.01% | 626 |
|
|
2022
Q1 | $3.16M | Buy |
19,376
+1,965
| +11% | +$299K | ﹤0.01% | 671 |
|
|
2021
Q4 | $2.95M | Buy |
17,411
+1,756
| +11% | +$326K | ﹤0.01% | 683 |
|
|
2021
Q3 | $2.96M | Buy |
15,655
+2,915
| +23% | +$547K | ﹤0.01% | 674 |
|
|
2021
Q2 | $2.16M | Buy |
12,740
+1,651
| +15% | +$242K | ﹤0.01% | 711 |
|
|
2021
Q1 | $1.57M | Buy |
11,089
+1,601
| +17% | +$241K | ﹤0.01% | 730 |
|
|
2020
Q4 | $1.23M | Sell |
9,488
-419
| -4% | -$55.9K | ﹤0.01% | 682 |
|
|
2020
Q3 | $1.44M | Sell |
9,907
-7,131
| -42% | -$1.01M | ﹤0.01% | 611 |
|
|
2020
Q2 | $2.52M | Buy |
17,038
+13,394
| +368% | +$1.81M | 0.01% | 507 |
|
|
2020
Q1 | $397K | Buy |
3,644
+865
| +31% | +$99.8K | ﹤0.01% | 842 |
|
|
2019
Q4 | $320K | Buy |
+2,779
| New | +$277K | ﹤0.01% | 947 |
|
|
2019
Q3 | – | Sell |
-5,075
| Closed | -$368K | – | 1009 |
|
|
2019
Q2 | $368K | Sell |
5,075
-6,918
| -58% | -$531K | ﹤0.01% | 912 |
|
|
2019
Q1 | $1.12M | Buy |
11,993
+5,794
| +93% | +$485K | ﹤0.01% | 900 |
|
|
2018
Q4 | $452K | Sell |
6,199
-32,096
| -84% | -$2.47M | ﹤0.01% | 954 |
|
|
2018
Q3 | $3.35M | Buy |
38,295
+33,911
| +774% | +$3.41M | 0.01% | 558 |
|
|
2018
Q2 | $432K | Sell |
4,384
-12,881
| -75% | -$1.28M | ﹤0.01% | 818 |
|
|
2018
Q1 | $2.06M | Buy |
+17,265
| New | +$2.23M | 0.01% | 561 |
|
Other funds holding ALNY
VPM
VCM
